14 Aug Guy LaTorre to Join Antibiotic Adjuvant as Chief Executive Officer
Gainesville, FL – The Company would like to announce the recent appointment of Mr. Guy LaTorre as Chief Executive Officer. Guy has over 25 years experience in the commercialization of medical devices in the regenerative medicine, oral care and IVD space. Prior to this, Guy has held numerous executive management positions including CEO of Breathtec Biomedical Inc., COO for Armor Dental Corp. and co-founder and Vice President of Business Development at Novamin Technology Inc.
“I am very excited about the direction of the Company, the quality of the team and the important work we are doing to address the overuse and misuse of antibiotics”. LaTorre says about joining the Antibiotic Adjuvant team.
David Flores, the acting CEO, will be the Chief Operating Officer. “We are extremely excited to bring someone with the experience that Guy has to our leadership team. It shows the potential that our product has and how we are evolving as a company.” Flores says about the news.
About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are developing our platform with our experienced team and selected nursing home staff including physicians, nurses and pharmacists.